Feasibility of p16 surrogate biomarker as adjunct diagnosis of oral and oropharyngeal malignancy in a resource-constrained country
Sign Up to like & getrecommendations! Published in 2020 at "Acta Oto-Laryngologica"
DOI: 10.1080/00016489.2020.1821915
Abstract: Abstract Background Cases of Human papillomavirus (HPV)-associated oral and oropharyngeal cancer are increasing. Proper diagnostic tools are required to detect HPV among patients, especially in areas where high technology is lacking. Aims To provide mapping… read more here.
Keywords: p16; surrogate biomarker; hpv; oral oropharyngeal ... See more keywords
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-3275
Abstract: Abstract Purpose: Atezolizumab + bevacizumab is the new standard of care for systemic treatment-naïve, unresectable hepatocellular carcinoma (HCC). This exploratory study investigated on-treatment alpha-fetoprotein (AFP) response as a potential surrogate biomarker of prognosis for the… read more here.
Keywords: surrogate biomarker; treatment; atezolizumab bevacizumab; potential surrogate ... See more keywords